Skip to Main Content

Paper Details

RSV genomic diversity and the development of a globally effective RSV intervention.
Vaccine
4
2021
COVID-19, RSV, RSV disease, Respiratory syncytial virus, SARS-CoV-2, SARS-CoV-2 genomics, children, infants, lower respiratory tract illness
Author NameAffiliation
Cécile ViboudNational Institutes of Health
Harry CampbellUniversity of Edinburgh
  • 1 - 2

Datasets

Release 1.2